Accelerating drug discovery with AI: Insights from Isomorphic Labs

Accelerating drug discovery with AI: Insights from Isomorphic Labs

Author: Lukas Biewald April 25, 2024 Duration: 1:10:23

In this episode of Gradient Dissent, Isomorphic Labs Chief AI Officer Max Jaderberg, and Chief Technology Officer Sergei Yakneen join our host Lukas Biewald to discuss the advancements in biotech and drug discovery being unlocked with machine learning.

With backgrounds in advanced AI research at DeepMind, Max and Sergei offer their unique insights into the challenges and successes of applying AI in a complex field like biotechnology. They share their journey at Isomorphic Labs, a company dedicated to revolutionizing drug discovery with AI. In this episode, they discuss the transformative impact of deep learning on the drug development process and Isomorphic Labs' strategy to innovate from molecular design to clinical trials.

You’ll come away with valuable insights into the challenges of applying AI in biotech, the role of AI in streamlining the drug discovery pipeline, and peer into the future of AI-driven solutions in healthcare.

Connect with Sergei Yakneen & Max Jaderberg:

https://www.linkedin.com/in/maxjaderberg/

https://www.linkedin.com/in/yakneensergei/

https://twitter.com/SergeiIakhnin

https://twitter.com/maxjaderberg

Follow Weights & Biases:

https://twitter.com/weights_biases

https://www.linkedin.com/company/wandb


Lukas Biewald hosts Gradient Dissent: Conversations on AI, a series that moves beyond theoretical discussions to examine how artificial intelligence is actually built and deployed. Each episode features a direct, unscripted talk with a leading practitioner-you’ll hear from engineers and researchers at places like NVIDIA, Meta, Google, Lyft, and OpenAI. The focus is on the tangible challenges and breakthroughs they encounter, from initial research to the complex reality of putting models into production. This isn't about abstract futures; it's a grounded look at the decisions shaping the field right now. Biewald, bringing his perspective from Weights & Biases, steers conversations toward the practical trade-offs and collaborative efforts that define modern AI work. For anyone in technology or business who wants to understand the mechanics behind the headlines, this podcast offers a rare, candid window into the process. You’ll come away with a clearer sense of how ideas become functional systems and what it really takes to operate at the cutting edge.
Author: Language: English Episodes: 100

Gradient Dissent: Conversations on AI
Podcast Episodes
Evaluating LLMs with Chatbot Arena and Joseph E. Gonzalez [not-audio_url] [/not-audio_url]

Duration: 55:32
In this episode of Gradient Dissent, Joseph E. Gonzalez, EECS Professor at UC Berkeley and Co-Founder at RunLLM, joins host Lukas Biewald to explore innovative approaches to evaluating LLMs.They discuss the concept of vi…
Snowflake’s CEO Sridhar Ramaswamy on 700+ LLM enterprise use cases [not-audio_url] [/not-audio_url]

Duration: 55:42
In this episode of Gradient Dissent, Snowflake CEO Sridhar Ramaswamy joins host Lukas Biewald to explore how AI is transforming enterprise data strategies.They discuss Sridhar's journey from Google to Snowflake, diving i…
Elevating ML Infrastructure with Modal Labs CEO Erik Bernhardsson [not-audio_url] [/not-audio_url]

Duration: 49:39
In this episode of Gradient Dissent, Erik Bernhardsson, CEO & Founder of Modal Labs, joins host Lukas Biewald to discuss the future of machine learning infrastructure. They explore how Modal is enhancing the developer ex…
From No-Code to AI-Powered Apps with Airtable’s Howie Liu [not-audio_url] [/not-audio_url]

Duration: 1:12:57
In this episode of Gradient Dissent, Howie Lou, CEO of Airtable, joins host Lukas Biewald to dive into Airtable's transformation from a no-code app builder to a platform capable of supporting complex AI-driven workflows.…
Reinventing AI Agents with Imbue CEO Kanjun Qiu [not-audio_url] [/not-audio_url]

Duration: 48:37
In this episode of Gradient Dissent, Kanjun Qiu, CEO and Co-founder of Imbue, joins host Lukas Biewald to discuss how AI agents are transforming code generation and software development. Discover the potential impact and…
From startup to $1.2B with Lambda’s Stephen Balaban [not-audio_url] [/not-audio_url]

Duration: 49:56
In this episode of Gradient Dissent, Stephen Balaban, CEO of Lambda Labs, joins host Lukas Biewald to discuss the journey of scaling Lambda Labs to an impressive $400M in revenue. They explore the pivotal moments that sh…